Conrado Garcia

Dr. Balmis 148, C.P. 06726
Doctores, DIF 06726, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Factors Associated With Delay in the Diagnosis and Treatment of Systemic Lupus Erythematosus: A Qualitative Study With Mexican Patients and Rheumatologists.

Factors Associated With Delay in the Diagnosis and Treatment of Systemic Lupus Erythematosus: A Qualitative Study With Mexican Patients and Rheumatologists.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: December 18, 2025

Knowledge and Behaviors in Reproductive Health Among Mexican Women With Autoimmune Rheumatic Diseases: Cross-sectional Study.

Knowledge and Behaviors in Reproductive Health Among Mexican Women With Autoimmune Rheumatic Diseases: Cross-sectional Study.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: April 09, 2025

Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy.

Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy.

Journal: RMD open

Published: February 03, 2025

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Journal: Reumatologia clinica

Published: June 21, 2024

The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.

The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.

Journal: Rheumatology international

Published: February 16, 2023

Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.

Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.

Journal: Clinical rheumatology

Published: May 18, 2022

Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study.

Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study.

Journal: Human vaccines & immunotherapeutics

Published: April 07, 2022

Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study.

Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study.

Journal: Clinical rheumatology

Published: February 16, 2022

Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.

Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.

Journal: RMD open

Published: November 15, 2021

Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.

Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.

Journal: Rheumatology international

Published: January 27, 2021

Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.

Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.

Journal: The Journal of rheumatology

Published: September 11, 2018

Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem.

Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem.

Journal: Annals of the rheumatic diseases

Published: April 19, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026